Found 23 matching trials
Two Step Haplo With Radiation Conditioning PHASE2 This phase II clinical trial evaluates whether a modified modality of condi...
Show More Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Learn More & Join Trial
2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies PHASE2 This phase II trial studies how well a 2-step approach to stem cell transpl...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Learn More & Join Trial
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant PHASE1 Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one o...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients PHASE2 Primary Objective:
To estimate the probability of molecular complete remis...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity PHASE2 This phase II trial studies the how well donor stem cell transplant works i...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Learn More & Join Trial
Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT PHASE1 Allogeneic hematopoietic cell transplantation(Allo-HSCT) is currently an ef...
Show More Location
Department of Hematopoietic Stem Cell Transplantation
Learn More & Join Trial
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation PHASE2 This phase 2 study aims to confirm the efficacy observed in the prior phase...
Show More Location
Washington University
Learn More & Join Trial
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) PHASE1 The purpose of this study is to see the effects of an investigational combi...
Show More Location
University of Miami
Learn More & Join Trial
Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2 PHASE1 The purpose of this study is to assess the safety and tolerability of an 'A...
Show More Location
King's College Hospital NHS Foundation Trust
Learn More & Join Trial
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) PHASE1 This is a phase I/II study of highly selected donor lymphocyte infusions in...
Show More Location
Universitätsklinikum
Learn More & Join Trial